Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
The Long Run with Luke Timmerman - Podcast autorstwa Timmerman Report
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.
The Long Run with Luke Timmerman - Podcast autorstwa Timmerman Report
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.